Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A combination of modified particle swarm optimization algorithm and support vector machine for gene selection and

Qi Shen1, Wei-Min Shi, Wei Kong

  • 1Chemistry Department, Zhengzhou University, Zhengzhou 450052, China; State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.

Talanta
|December 17, 2008
PubMed
Summary

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conductive polyethersulfone membrane facilely prepared by simultaneous phase inversion method for enhanced anti-fouling and separation under low driven-pressure.

Journal of environmental management·2021
Same author

Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: "IFN-High," "NE-High," and "Mixed".

Mediators of inflammation·2021
Same author

Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas.

The American journal of surgical pathology·2021
Same author

Near-Infrared-Light Remote-Controlled Activation of Cancer Immunotherapy Using Photothermal Conjugated Polymer Nanoparticles.

Advanced materials (Deerfield Beach, Fla.)·2021
Same author

Atomic heterojunction-induced accelerated charge transfer for boosted photocatalytic hydrogen evolution over 1D CdS nanorod/2D ZnIn<sub>2</sub>S<sub>4</sub> nanosheet composites.

Journal of colloid and interface science·2021
Same author

Ultrathin Two-Dimensional Plasmonic PtAg Nanosheets for Broadband Phototheranostics in Both NIR-I and NIR-II Biowindows.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2021

This study introduces a novel gene selection method using modified discrete particle swarm optimization (PSO) and support vector machines (SVM) for accurate tumor classification from microarray data.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Microarray data analysis faces challenges due to a high number of genes versus limited tissue samples, risking overfitting.
  • Effective gene selection is crucial for reliable tissue classification in high-dimensional genomic studies.

Purpose of the Study:

  • To develop and evaluate a hybrid approach combining modified discrete particle swarm optimization (PSO) and support vector machines (SVM) for enhanced tumor classification.
  • To address the challenge of gene selection in high-dimensional microarray data analysis.

Main Methods:

  • Utilized a modified discrete particle swarm optimization (PSO) algorithm for efficient gene selection.
  • Employed support vector machines (SVM) as a classifier to evaluate the performance of selected genes.

Related Experiment Videos

  • Applied the combined PSO-SVM approach to microarray data from normal and colon tumor tissues.

    • Main Results:

    • The proposed PSO-SVM method demonstrated good prediction performance in classifying colon tumor tissues.
    • Successfully identified indicative genes for tissue classification, mitigating issues associated with high-dimensional data.
    • Validated the efficacy of modified PSO as a tool for gene selection and high-dimensional data mining.

    Conclusions:

    • The hybrid PSO-SVM approach offers a robust solution for gene selection in microarray studies.
    • This method effectively improves tumor classification accuracy and overcomes limitations of small sample sizes.
    • Modified discrete PSO is a valuable technique for analyzing complex, high-dimensional biological data.